Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Antiepileptic drugs as prophylaxis for de novo brain tumour-related epilepsy after craniotomy: a systematic review and meta-analysis of harm and benefits

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Understanding the relationship between cognitive performance and function in daily life after traumatic brain injury

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Misfolded SOD1 inclusions in patients with mutations in C9orf72 and other ALS/FTD-associated genes

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. The risk of developing a meningioma during and after pregnancy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Impact of time to treatment initiation for patients with oral cavity squamous cell carcinoma: a population-based, retrospective study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Somatostatin receptor-targeted radiopeptide therapy in treatment-refractory meningioma: Individual Patient Data Meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Randomized blinded trial of automated REBOA during CPR in a porcine model of cardiac arrest

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVES: To investigate potential harm and benefits of antiepileptic drugs (AED) given prophylactically to prevent de novo brain tumour-related epilepsy after craniotomy.

METHODS: Randomised controlled trials (RCT) and retrospective studies published before 27 November 2018 were included. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were applied. Eligible patients were diagnosed with a brain tumour, were seizure naïve and underwent craniotomy. The random effects model was used for quantitative synthesis. The analysis was adjusted for the confounding effect of including patients with a history of seizure prior to study inclusion.

RESULTS: A total of 454 patients received prophylactic AED whereas 333 were allocated to placebo or no treatment. Two RCTs and four retrospective studies were identified. The OR was 1.09 (95% CI 0.7 to 1.8, p=0.7, I2=5.6%, χ2 p=0.5), indicating study consistency and no significant differences. An additional two RCTs and one retrospective study combined craniotomy and diagnostic biopsy, and were subgroup analysed-which supported no difference in odds for epilepsy.

CONCLUSIONS: A prophylactic effect of AED could not be demonstrated (nor rejected statistically). Levetiracetam was associated with less adverse effects than phenytoin. The potential harm of AED was not balanced by the potential prophylactic benefit. This study suggests that prophylactic AED should not be administered to prevent brain tumour-related epilepsy after craniotomy.

Original languageEnglish
JournalJournal of neurology, neurosurgery, and psychiatry
Volume90
Issue number5
Pages (from-to)599-607
Number of pages9
ISSN0022-3050
DOIs
Publication statusPublished - May 2019

ID: 58216832